epanolol has been researched along with Angina Pectoris in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (59.26) | 18.7374 |
| 1990's | 11 (40.74) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberti, KG; Boon, NA; MacGregor, IR; Perrie, AM; Riemersma, RA; Stenhouse, F; Wright, RA | 1 |
| Elborn, JS; Erwin, C; Khan, MM; Nicholls, DP; Onuoha, G; Riley, M; Shaw, C; Stanford, CF | 1 |
| Rydén, L | 2 |
| Blake, P; Lewis, JA | 1 |
| Boberg, J; Larsen, FF; Pehrsson, SK | 1 |
| Elborn, JS; Khan, MM; Nicholls, DP; Riley, M; Stanford, CF | 1 |
| Harvengt, C | 1 |
| De Geest, H; Piessens, J; Vandenbosch, H | 1 |
| Berry, SC; Blake, P; Godley, M; Ratcliffe, M; Readman, A | 1 |
| Cockshott, ID; Hosie, J; Petrie, JC; Scott, AK | 1 |
| Cockshott, ID; Marlier, R; McAinsh, J | 1 |
| Cockshott, ID | 1 |
| Akhras, F; Jackson, G | 1 |
| Abrahamsen, AM; Omland, TM; von Brandis, C | 1 |
| Adam, G; Akhras, F; Chambers, J; Jackson, G; Ong, ML | 1 |
| Boberg, J | 1 |
| Godley, MJ; Ratcliffe, MJ | 1 |
| Clark-Turner, N | 1 |
| Readman, AS | 1 |
| Corbeij, HM; Huige, MC; Kragten, JA; Vermeulen, A; Withagen, AJ | 1 |
| Evans, T | 1 |
| Jern, S | 1 |
| Blake, P | 1 |
| Abramowicz, M; Berkenboom, GM; Degre, SG; Ibrahim, T | 1 |
| Erikssen, J; Otterstad, JE; Rollag, A | 1 |
1 review(s) available for epanolol and Angina Pectoris
| Article | Year |
|---|---|
An overview of clinical trial experience with epanolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Clinical Trials as Topic; Humans; Propanolamines | 1989 |
21 trial(s) available for epanolol and Angina Pectoris
| Article | Year |
|---|---|
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Blood Glucose; Blood Pressure; Double-Blind Method; Humans; Insulin; Lipids; Male; Metoprolol; Nifedipine; Plasminogen Activator Inhibitor 1; Propanolamines; Risk Factors; Tissue Plasminogen Activator | 1994 |
Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atrial Natriuretic Factor; Benzeneacetamides; Cardiac Output; Diltiazem; Double-Blind Method; Exercise; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Propanolamines | 1993 |
Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Double-Blind Method; Exercise Test; Humans; Metoprolol; Physical Endurance; Physical Exertion; Propanolamines | 1992 |
The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Benzeneacetamides; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines | 1992 |
Comparative effects of epanolol and diltiazem on exercise performance and respiratory gas exchange in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Benzeneacetamides; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Humans; Lactates; Lactic Acid; Male; Middle Aged; Oxygen; Propanolamines; Pulmonary Gas Exchange | 1992 |
Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Blood Pressure; Circadian Rhythm; Electrocardiography; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Time Factors | 1991 |
A comparison of epanolol and nifedipine in stable angina patients: results of a multicentre trial.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Clinical Protocols; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; Patient Satisfaction; Propanolamines; Quality of Life | 1991 |
Pharmacokinetics of epanolol (ICI 141,292) in healthy young volunteers and comparative data in elderly patients with angina and subjects with renal or hepatic impairment.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aging; Angina Pectoris; Benzeneacetamides; Female; Half-Life; Humans; Injections, Intravenous; Kidney Diseases; Liver Diseases; Male; Middle Aged; Propanolamines; Reference Values; Species Specificity | 1989 |
Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzeneacetamides; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Propanolamines | 1989 |
Dose finding in angina--results with epanolol.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzeneacetamides; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Norway; Propanolamines | 1989 |
Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzeneacetamides; Chronic Disease; Double-Blind Method; Exercise; Female; Hemodynamics; Humans; Male; Mental Disorders; Middle Aged; Propanolamines; Randomized Controlled Trials as Topic | 1989 |
Results of a long term multicentre study in Sweden.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzeneacetamides; Exercise Test; Humans; Multicenter Studies as Topic; Propanolamines; Sweden | 1989 |
Rationale and statistical methodology for the VISA studies.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Europe; Humans; Multicenter Studies as Topic; Propanolamines; Research Design | 1989 |
Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Drug Tolerance; Female; Humans; Male; Metoprolol; Middle Aged; Multicenter Studies as Topic; Propanolamines | 1989 |
Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Double-Blind Method; Drug Tolerance; Female; Hemodynamics; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nifedipine; Nitroglycerin; Propanolamines; Randomized Controlled Trials as Topic | 1989 |
Efficacy of epanolol versus metoprolol in angina pectoris. Results from the Swedish Multicenter Study of Exercise Tolerance. The Swedish Multicenter Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Benzeneacetamides; Exercise Test; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Multicenter Studies as Topic; Propanolamines; Sweden | 1989 |
Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Metoprolol; Propanolamines | 1989 |
The effects of epanolol on quality of life.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Humans; Propanolamines; Quality of Life; Surveys and Questionnaires | 1989 |
An overview of clinical trial experience with epanolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Clinical Trials as Topic; Humans; Propanolamines | 1989 |
Comparison of the immediate effects of two beta-blocking drugs: a nonselective and a cardioselective with modest ISA in exercise-induced angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzeneacetamides; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Random Allocation; Sympathomimetics | 1987 |
A new water-soluble, selective beta-blocker with intrinsic sympathomimetic activity (ICI 141.292) in angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzeneacetamides; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Random Allocation | 1988 |
6 other study(ies) available for epanolol and Angina Pectoris
| Article | Year |
|---|---|
Epanolol as a model for assessing patient preference in anti-anginal drug therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Choice Behavior; Female; Humans; Male; Metoprolol; Middle Aged; Models, Biological; Nifedipine; Patient Compliance; Propanolamines; Quality of Life | 1992 |
Drugs recently released in Belgium. Epanolol--Clodronate dinatrium.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Bone Resorption; Clodronic Acid; Humans; Propanolamines | 1992 |
Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzeneacetamides; Blood Pressure; Female; Half-Life; Heart Rate; Humans; Male; Propanolamines | 1990 |
Pharmacokinetics of epanolol in elderly patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Blood Pressure; Female; Half-Life; Humans; Male; Propanolamines; Radioimmunoassay | 1990 |
Patient preference in antianginal therapy. Proceedings of a symposium. Madeira, 21-22 October, 1988.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Humans; Propanolamines | 1989 |
Left ventricular function during treatment with either metoprolol or epanolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Blood Pressure; Heart Rate; Humans; Metoprolol; Propanolamines | 1989 |